Amgen Seminar Series: Discovery of Non-opioid Therapeutics for Pain from Human Genetics and Natural Products
Date and time
Location
Community Room
953 Indiana Street San Francisco, CA 94107Description
Amgen Seminar Series: Discovery of Non-opioid Therapeutics for Pain from Human Genetics and Natural Products
Date: Wednesday, April 3, 2019
Time: 12:00–1:30pm
Place: 953 Indiana Street, San Francisco
Lunch Served
About the Seminar:
Please join us for the next Amgen Seminar Series where SiteOne will share their story and talk about Discovery of Non-opioid Therapeutics for Pain from Human Genetics and Natural Products.
Speakers:
JOHN MULCAHY - Co-founder and Vice President of Research at SiteOne Therapeutics
John Mulcahy PhD, has a background in synthetic organic chemistry, drug discovery and neuroscience. As a graduate student, he developed technology to prepare synthetic analogues of natural toxins that are potent, small molecule inhibitors of mammalian voltage-gated sodium ion channels. SiteOne has leveraged this technology, as well as structural insights into the binding pose of the natural toxins, to design novel drug candidates with exquisite selectivity for the human nociceptive sodium channel, NaV1.7, as non-opioid therapeutics for the treatment of pain. John received a PhD in Chemistry from Stanford University and AB in Chemistry, Physics and Classics from Harvard.